Once-weekly (70 mg/m2) versus twice weekly (56 mg/m2) dosing of carfilzomib (CFZ) for patients (pts) with relapsed and/or refractory multiple myeloma (RRMM).

被引：0
|
作者：
Moreau, Philippe
Stewart, A. Keith
Dimopoulos, Meletios A.
Siegel, David Samuel DiCapua
Facon, Thierry
Berenson, James R.
Raje, Noopur S.
Berdeja, Jesus G.
Orlowski, Robert Z.
Yang, Hui
Ma, Haijun
Karina Klippel, Zandra
Zahlten-Kumeli, Anita
Mezzi, Khalid
Iskander, Karim
Mateos, Maria-Victoria
机构：
[1] Univ Hosp Nantes, Nantes, France
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ Athens, Athens, Greece
[4] Hackensack Univ Med Ctr, Hackensack, NJ USA
[5] Reg Univ Hosp Lille, Lille, France
[6] Inst Myeloma & Bone Canc Res, West Hollywood, CA USA
[7] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[8] Sarah Cannon Res Inst, Nashville, TN USA
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[10] Amgen Inc, Thousand Oaks, CA 91320 USA
[11] Univ Salamanca Hosp, IBSAL, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19505
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Once-weekly (70 mg/m2) vs twice-weekly (56 mg/m2) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, ARROW, and CHAMPION-1 trials
    Moreau, Philippe
    Stewart, Keith A.
    Dimopoulos, Meletios
    Siegel, David
    Facon, Thierry
    Berenson, James
    Raje, Noopur
    Berdeja, Jesus G.
    Orlowski, Robert Z.
    Yang, Hui
    Ma, Haijun
    Klippel, Zandra
    Zahlten-Kumeli, Anita
    Mezzi, Khalid
    Iskander, Karim
    Mateos, Maria-Victoria
    CANCER MEDICINE, 2020, 9 (09): : 2989 - 2996
  • [2] Efficacy and Safety of Carfilzomib, Dexamethasone, Daratumumab (KdD) Twice-Weekly at 56 mg/m2 and Once-Weekly at 70 mg/m2 in Relapsed or Refractory Multiple Myeloma (RRMM): Cross-Study Comparison of the CANDOR and EQUULEUS studies
    Leleu, Xavier
    Beksac, Meral
    Chou, Takaaki
    Dimopoulos, Meletios
    Yoon, Sung-Soo
    Prince, Henry Miles
    Pour, Ludek
    Shelekhova, Tatiana
    Chari, Ajai
    Khurana, Monica
    Obreja, Mihaela
    Qi, Ming
    Oriol, Albert
    Siegel, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S288 - S288
  • [3] Efficacy and safety of carfilzomib, dexamethasone, daratumumab (KdD) twice-weekly at 56 mg/m2 and once-weekly at 70 mg/m2 in relapsed or refractory multiple myeloma (RRMM): Cross-study comparison of candor and MMY1001.
    Leleu, Xavier
    Beksac, Meral
    Chou, Takaaki
    Dimopoulos, Meletios A.
    Yoon, Sung-Soo
    Prince, H. Miles
    Pour, Ludek
    Shelekhova, Tatiana
    Chari, Ajai
    Khurana, Monica
    Obreja, Mihaela
    Qi, Ming
    Oriol, Albert
    Siegel, David Samuel DiCapua
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Carfilzomib weekly 20/56 mg/m2, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
    Richez, Valentine
    Gruchet, Cecile
    Guidez, Stephanie
    Fouquet, Guillemette
    Azais, Isabelle
    Durand, Geraldine
    Javaugue, Vincent
    Brigaud, Antoine
    Plasse, Florent
    Diolez, Jeremie
    Machet, Antoine
    Moya, Niels
    Gardeney, Helene
    Franques, Paul
    Bobin, Arthur
    Levy, Anthony
    Sabirou, Florence
    Bonnin, Anthony
    Dieval, Celine
    Primault, Sylvain
    Barrier, Jocelyn
    Fleck, Emmanuel
    Bouyier, Sabrina
    Daras, Claire
    Princet, Isabelle
    Bauwens, Delphine
    Legros, Laurence
    Fuzibet, Jean-Gabriel
    Gil, Angela
    Bridoux, Frank
    Avet-Loiseau, Herve
    Leleu, Xavier
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : E17 - E20
  • [5] Carfilzomib Weekly 20/56mg/m2, Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma
    Valentine, Richez
    Guidez, Stephanie
    Azais, Isabelle
    Durand, Geraldine
    Javaugue, Vincent
    Brigaud, Antoine
    Plasse, Florent
    Diolez, Jeremie
    Machet, Antoine
    Moya, Niels
    Gruchet, Cecile
    Bobin, Arthur
    Levy, Anthony
    Sabirou, Florence
    Bonnin, Anthony
    Dieval, Celine
    Primault, Sylvain
    Barrier, Jocelyn
    Fleck, Emmanuel
    Daras, Claire
    Princet, Isabelle
    Bauwens, Delphine
    Fouquet, Guillemette
    Bridoux, Frank
    Loiseau, Herve Avet
    Leleu, Xavier
    BLOOD, 2017, 130
  • [6] Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States
    Kumar, Shaji K.
    Majer, Istvan
    Panjabi, Sumeet
    Medhekar, Rohan
    Campioni, Marco
    Dimopoulos, Meletios A.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (06) : 687 - 696
  • [7] Carfilzomib weekly 20/56mg/m2, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
    Richez, Valentine
    Guidez, Stephanie
    Azais, Isabelle
    Durand, Geraldine
    Javaugue, Vincent
    Brigaud, Antoine
    Machet, Antoine
    Moya, Niels
    Gruchet, Cecile
    Bobin, Arthur
    Levy, Anthony
    Sabirou, Florence
    Dieval, Celine
    Fleck, Emmanuel
    Princet, Isabelle
    Bauwens, Delphine
    Fouquet, Guillemette
    Bridoux, Frank
    Avet-Loiseau, Herve
    Leleu, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Cost-effectiveness of once weekly carfilzomib 70 mg/m2 plus dexamethasone in patients with relapsed and refractory multiple myeloma in the United States.
    Kumar, Shaji
    Majer, Istvan
    Panjabi, Sumeet
    Malacan, Jean
    Medhekar, Rohan
    Campioni, Marco
    Dimopoulos, Meletios A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Bortezomib: Once-Weekly 1.6mg/m2 Maybe a Better Choice Compared with Twice-Weekly 1.3mg/m2 in Newly Dignosed Multiple Myeloma
    Li, Yubin
    Li, Fangfang
    Song, Wangshan
    Zhan, Zhumei
    Li, Xiangxin
    Wang, Lingling
    Li, Fanglin
    Hou, Ming
    Li, Hao
    Wang, Luqun
    BLOOD, 2019, 134
  • [10] Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized ARROW study)
    Moreau, Philippe
    Kumar, Shaji
    Boccia, Ralph
    Iida, Shinsuke
    Goldschmidt, Hartmut
    Cocks, Kim
    Trigg, Andrew
    Zahlten-Kumeli, Anita
    Yucel, Emre
    Panjabi, Sumeet S.
    Dimopoulos, Meletios
    LEUKEMIA, 2019, 33 (12) : 2934 - 2946
12345